Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
These signs might mean a food issue or something else
Lilly has also identified products with dangerous potency issues
Prospective randomized clinical trials with longer follow-up periods are urgently needed to determine the optimal medical approach for postbariatric patients with secondary weight regain
You should also schedule an evaluation if: Your appetite hasnt changed at all Weight continues to increase despite treatment You suspect an underlying medical condition Side effects are interfering with your ability to follow your treatment plan A thorough assessment can help identify obstacles and guide the next steps
In September, Pfizer offered to buy Metsera for $4.9 billion, but less than a month later, Novo Nordisk made an unsolicited bid of $6.0 billion in cash
US$ 22.35
US$ 23.90
US$ 26.39
US$ 24.38
US$ 22.93
